Page last updated: 2024-08-22

clodronic acid and Lymph Node Metastasis

clodronic acid has been researched along with Lymph Node Metastasis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Gong, FL; Guo, XL; Li, YS; Wang, L; Yang, XX; Yu, LG; Zhang, XK; Zhao, L	1
Blomqvist, C; Saarto, T; Vehmanen, L; Virkkunen, P	1
Blomqvist, C; Elomaa, I; Saarto, T; Virkkunen, P	1

Trials

2 trial(s) available for clodronic acid and Lymph Node Metastasis

Article	Year
Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients. Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:7 Topics: Aged; Antimetabolites; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Female; Follow-Up Studies; History, 17th Century; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Receptors, Estrogen; Survival Analysis	2004
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-01, Volume: 19, Issue:1 Topics: Adult; Aged; Antimetabolites; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Survival Rate	2001

Article

Year

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.

Acta oncologica (Stockholm, Sweden), 2004, Volume: 43, Issue:7

Topics: Aged; Antimetabolites; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Female; Follow-Up Studies; History, 17th Century; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Receptors, Estrogen; Survival Analysis

2004

Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-01, Volume: 19, Issue:1

Topics: Adult; Aged; Antimetabolites; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Survival Rate

2001

Other Studies

1 other study(ies) available for clodronic acid and Lymph Node Metastasis

Article	Year
Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression. Biochemical pharmacology, 2020, Volume: 178 Topics: Adenocarcinoma; Animals; Bevacizumab; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Clodronic Acid; Coculture Techniques; Disease Progression; Female; Galectin 3; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Lymphatic Metastasis; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Pectins; Signal Transduction; Sorafenib	2020

Article

Year

Galectin-3 expression and secretion by tumor-associated macrophages in hypoxia promotes breast cancer progression.

Biochemical pharmacology, 2020, Volume: 178

Topics: Adenocarcinoma; Animals; Bevacizumab; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Clodronic Acid; Coculture Techniques; Disease Progression; Female; Galectin 3; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Lymphatic Metastasis; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; NF-kappa B; Pectins; Signal Transduction; Sorafenib

2020